Parenteral fluid regimens for improving functional outcome in people with acute stroke

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 9, 2015, Pages

  Visvanathan, Akila ^a   Dennis, Martin ^b   Whiteley, William ^b  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTONIC SOLUTION; INFUSION FLUID; ISOTONIC SOLUTION; SODIUM CHLORIDE; COLLOID; CRYSTALLOID; ORAL REHYDRATION SOLUTION;

BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; COLLOID; CRYSTALLOID; DEATH; DEPENDENT PERSONALITY DISORDER; DISEASE ASSOCIATION; DISEASE DURATION; FLUID THERAPY; FUNCTIONAL OUTCOME; HUMAN; LUNG EDEMA; META ANALYSIS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT DURATION; ADMINISTRATION AND DOSAGE; ADULT; ADVERSE EFFECTS; MORTALITY; PROCEDURES; STROKE REHABILITATION;

ADULT; COLLOIDS; FLUID THERAPY; HUMANS; ISOTONIC SOLUTIONS; REHYDRATION SOLUTIONS; STROKE; STROKE REHABILITATION;

EID: 85002864132     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011138.pub2     Document Type: Review

References (90)

1. Aichner FT, Fazekas F, Brainin M, Polz W, Mamoli B, Zeiler K. Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke 1998;29:743-9.
2. Bayer AJ, Pathy MSJ, Newcombe R. Double-blind randomised trial of intravenous glycerol in acute stroke. The Lancet 1987;1:405-8.
3. Borenstein N, Regev I, Flechater S, Streifler M, Vardi J. Dextran-40 in nonhemorrhagic cerebrovascular accidents. Harefuah 1981;100(10):455.
4. Fawer R, Justafre JC, Berger JP, Schelling JL. Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke 1978;9:484-6.
5. Friedli W, Imbach P, Ghisleni-Steinegger S, Schwarz C, Maire P. Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift 1979;109(20):737-42.
6. Gilroy J, Barnhart M, Meyer JS. Treatment of acute stroke with Dextran 40. JAMA 1969;210(2):293-8.
7. Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke 2011;42:119-27.
8. Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, et al. High-dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double-blind, phase 3, placebo-controlled trial. The Lancet Neurology 2013;12:1049-58.
9. Larsson O, Marinovich N, Barber K. Double-blind trial of glycerol therapy in early stroke. The Lancet 1976;1:832-4.
10. Matthews WB, Oxbury JM, Grainger KM, Greenhall RC. A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain 1976;99:193-206.
11. Rudolf J. Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II. safety study. Cerebrovascular Diseases 2002;14(1):33-41.
12. Yu Y, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 1992;23(7):967-71.
13. Balcarce PE, Vila JF, Fustinoni O. Isovolaemic haemodilution with plasma in acute ischaemic stroke. Revista Neurológica Argentina 1991;16:154-60.
14. Brownsell MD, Mealey PJ, Watkins CL, Jack C, Leathley MJ. A feasibility study of differing methods of parenteral hydration post-stroke. Proceedings of the Consensus Conference on Stroke Treatment and Service Delivery. 7-8 November 2000; Edinburgh, UK. Royal College of Physicians of Edinburgh, 2000:41.
15. Challiner YC, Jarrett D, Hayward MJ, al-Jubouri MA, Julious SA. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgraduate Medical Journal 1994;70(821):196-7.
16. Diringer MN, Scalfani MT, Zazulia AR, Videen TO, Dhar R. Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke. NeuroCritical Care 2011;14(1):11-7.
17. Frei A, Cottier C, Wunderlich P. Glycerol and dextran combined in the therapy of acute stroke. A placebo-controlled, double-blind trial with a planned interim analysis. Stroke 1987;18(2):373-9.
18. Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke - I: physiological responses and safety results. Stroke 2006;37:2100-16.
19. Goslinga H, Eijzenbach V, Heuvelmans JH, van der Laan de Vries, Melis V, Bezemer PD. Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke. Stroke 1992;23(2):181-8.
20. Grauer MT, Woessner R, Seltmann A, Windisch F, Schenk JF, Wenzel E, et al. Therapeutic safety of a high-dose volume therapy with hydroxyethyl starch in patients with acute stroke under intensive care monitoring. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie 1999;34:S87-8.
21. Grauer MT, Baus D, Woessner R, Bepperling F, Kahles T, Georgi S, et al. Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study. Critical Care 2001;5(1):S53-4.
22. Greenhall RCD. Clinical and neuropathological observations in a controlled trial of low molecular weight dextran (LMD) in acute cerebral infarction. Neuropathology and Applied Neurobiology 1974;1(1):108.
23. Haass A, Kroemer H, Jager H, Muller K, Decker I, Wagner EM, et al. Dextran 40 or HES 200/0.5? Haemorheology on long-time treatment of ischaemic stroke. Deutsche Medizinische Wochenschrift 1986;111:1681-6.
24. Hamamoto M, Nagao T, Kanda A, Ichiseki H, Miyazaki T, Terashi A. Hypervolemic hemodilution therapy for the elderly patients with atherothrombotic and hemodynamic ischemic stroke. Journal of Stroke and Cerebrovascular Diseases 1992;2(1):S136.
25. Han J, Yang F, Jiang W, Zhang G, Liu Z, Liu X, et al. Hydroxyethyl starch 130/0.4 and sodium chloride injection as adjunctive therapy in patients with cerebral hypoperfusion. BMC Neurology 2012;12:127.
26. Haring HP, Pohl P, Schimetta W, Polz W, Aichner F. Hydroxyethyl starch - influence of molar substitution on haemorheologic parameters: a clinical double blind study. Clinical Hemorheology 1994;14(1):11-8.
27. Hartmann A, Tsuda Y, Lagreze H. Effect of hypervolaemic haemodilution of regional cerebral blood flow in patients with acute ischaemic stroke: a controlled study with hydroethyl starch. Journal of Neurology 1987;235:34-8.
28. Hemmati A. Assessment the effect of albumin compared with placebo on functional outcome after ischemic stroke in 18-83 year old patients with ischemic stroke in MCA territory referred to Golestan Hospital of Ahvaz. Iranian Registry of Clinical Trials http://www.irct.ir/searchresult.php?keyword=randomly&field=&id=4606&number=1&prt=1084&total=10&m=1 2012.
29. Hemodilution in Stroke Study Group. Hypervolemic hemodilution treatment of acute stroke. Results of a randomized multicenter trial using pentastarch. Stroke 1989;20(3):317-23.
30. Koltringer P, Langsteger W, Reisecker F, Eber O. Hypervolemic haemodilution and completed stroke: how important is the application time for its effect?. Neurological Research 1992;14:171-3.
31. Kramer W, Rompel C, Umlauf B, Ulm K. Controlled, comparative blind study on the effect of glycerin infusions in recent ischemic crises. Medizinische Welt 1981;32:813-6.
32. Kroemer H, Haass A, Muller K, Jager H, Wagner EM, Heimburg P, et al. Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroethyl starch 200/0.5. European Journal of Clinical Pharmacology 1987;31:705-10.
33. Lee KS. A placebo comparative, double blinded, randomized, multicenter study to evaluate the efficacy and safety of albumin therapy in acute ischemic stroke patients in Korea. Clinical Research Information Service (CRIS) Republic of Korea 2012.
34. Lin LC, Hsiao KY, Tsai YH, Lai SL, Lei CC, Hsiao CT. Hydration status and stroke-in-evolution after ischemic stroke: a preliminary study. International Journal of Stroke 2013;8(7):E52.
35. Lye M. Comparison of intravenous and subcutaneous bolus infusion in post-stroke hydration. www.controlled-trials.com/mrct/trial/stroke/1046/18319.html 2012.
36. Morgenthaler M, Woessner R, Treib J. Is there new safety information to be gained out of the use of thrombelastography in stroke patients receiving hydroxyethyl starches for treatment?. Cerebrovascular Diseases 2010;29 Suppl 2:235.
37. Oghbaei M. The effect of intravenous albumin in mortality and morbidity of intracranial hemorrhage; a randomized clinical trial. Iranian Registry of Clinical Trials http://irct.ir/searchresult.php?keyword=fibrinogen&id=8240&field=&number=1&prt=31&total=5&m=1 2012.
38. Popa G, Popa C, Stanescu A, Ionescu G, Lugoji G, Radula D, et al. Haemodilution therapy in acute ischaemic stroke. Revue Roumaine de Medecine Neurologie et Psychiatrie 1989;27:79-90.
39. Qizilbash N, Murphy M. Meta-analysis of trials of dextran in acute stroke. Age and Ageing 1993;22:14.
40. Schneider R, Hacke W, Kiesewetter H, Jung F. Hemodilution in acute ischemic insults. Comparative study on the clinical and hemorheologic effectiveness of 10% HES 200/0.5 and 10% dextran 40. Fortschritte der Medizin 1985;103(44):1031-4.
41. Shalilahmadi D. Assessment of the effect of albumin compared with placebo on the reduction of the hematoma volume in patients with hemorrhagic stroke referred to Ahvaz Golestan Hospital. Iranian Registry of Clinical Trials http://irct.ir/searchresult.php?keyword=fibrinogen&id=8574&field=&number=1&prt=73&total=5&m=1 2013.
42. Shin DH, Moon GJ, Bang OY. Albumin therapy in acute stroke patients. Journal of Neurology 2007;254(7):870-8.
43. Spudis EV, de la Torre E, Pikula L. Management of completed strokes with dextran 40. A community hospital failure. Stroke 1973;4(6):895-7.
44. Staedt U, Schlierf G, Oster P, Mechtersheimer U, Baessler G, Seufzer U. Hypervolemic hemodilution with 10% HES 200/0.5 and 10% Dextran 40 in patients with ischemic stroke. Cerebral Ischemia and Hemorheology. Springer, 1987:429-35.
45. Tessitore A, Diaco S, Battaglia A. Hydroxyethyl starch in the treatment of ischemic stroke. Quaderni Di Medicina E Chirurgia 1990;6(3):350-2.
46. Torun S, Ozoner Z, Gucuyener D, Uzuner N, Ozdemir G. The effects of isovolemic hemodilution in acute ischemic stroke (a randomized controlled clinical trial). European Journal of Neurology 1995;2 Suppl 1:78.
47. Treib J, Behnke S, Seltmann A, Fischer C, Windisch F, Grauer MT, et al. Effects of a high-dose hypervolemic volume therapy using HES 200/0.5 or HES 70/0.5 on hemodynamics, hemorheology and coagulation in patients suffering from acute stroke. Results of a randomised double-blind study. Cerebrovascular Diseases 1999;9 Suppl 1:101.
48. Vorstrup S, Andersen A, Juhler M, Brun B, Boysen G. Hemodilution increases cerebral blood flow in acute ischemic stroke. Stroke 1989;20:84-9.
49. Wagner I, Hauer E-M, Staykov D, Volbers B, Dorfler A, Schwab S, et al. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke 2011;42(6):1540.
50. Woessner R, Grauer MT, Dieterich HJ, Bepperling F, Baus D, Kahles T, et al. Influence of a long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 or crystalloid solution on hemodynamics, rheology and hemostasis in patients with acute ischemic stroke. Pathophysiology of Haemostasis and Thrombosis 2004;33(3):121-6.
51. Wu SH. Mannitol in the treatment of acute cerebral infarction (50 cases analyses). Journal of Stroke and Neurological Diseases 1993;10(3):177-8.
52. Yu L, Zhao Y. Efficacy of aescine sodium, mannitol, and albumin on cerebral post-infarction. China Pharmacist 2003;6(12):801-2.
53. Zhao PX. Clinical observation on the effect of 20% mannitol in treating cerebral thrombosis. Chinese Journal of Neurology & Psychiatry 1987;20(3):169-72.
54. Suwanwela NC. Randomised controlled study of the effectiveness of iv fluid infusion in patients with acute ischemic stroke (IVIS). clinicaltrials.gov/ct2/show/NCT02003794 (accessed May 2015).
55. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989; Vol. 20, issue 6:828. [PUBMED: 2728057]
56. Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke 2007;38(3):1091-6. [PUBMED: 17272767]
57. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010;303(12):1180-7.
58. Britton M, de Faire U, Helmers C. Hazards of therapy for excessive hypertension in acute stroke. Acta Medica Scandinavica 1980;207(4):253-7. [PUBMED: 7386220]
59. Chang TS, Jensen MB. Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI:]
60. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P. A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 1993;24(8):1178-81. [PUBMED: 8342193]
61. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
62. Feigin VL. Stroke epidemiology in the developing world. The Lancet 2005;365(9478):2160-1. [PUBMED: 15978910]
63. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. The Lancet 2014;18(383):245-54.
64. Finestone HM, Foley NC, Woodbury MG, Greene-Finestone L. Quantifying fluid intake in dysphagic stroke patients: a preliminary comparison of oral and nonoral strategies. Archives of Physical Medicine and Rehabilitation 2001;82(12):1744-6. [PUBMED: 11733894]
65. Gordon C, Hewer RL, Wade DT. Dysphagia in acute stroke. British Medical Journal 1987;295(6595):411-4. [PUBMED: 3115478]
66. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from www.gradepro.org.
67. Granger CV, Dewis LS, Peters NC, Sherwood CC, Barrett JE. Stroke rehabilitation: analysis of repeated Barthel Index measures. Archives of Physical Medicine and Rehabilitation 1979;60(1):14-7. [PUBMED: 420565]
68. Heros R, Korosue K. Hemodilution for cerebral ischaemia. Stroke 1989;20:423-7.
69. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [PUBMED: 12958120]
70. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
71. Howard G, Hess DC, Howard VJ. Wisdom and determination in the ongoing pursuit of the ever-elusive neuroprotective agent. Stroke 2011;42(6):1505-6.
72. Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. The Lancet 1988;1:318-21.
73. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44(3):870-947. [PUBMED: 23370205]
74. Kelly J, Rudd A, Lewis RR, Coshall C, Parmar K, Moody A, et al. Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D-dimers. Journal of Thrombosis and Haemostasis 2004;2:1321-6.
75. Koller M, Haenny P, Hess K, Weniger D, Zangger P. Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke 1990;21(10):1429-34.
76. Kositzke JA. A question of balance - dehydration in the elderly. Journal of Gerontological Nursing 1990;16(5):4-11. [PUBMED: 2358648]
77. Lopez-Espuela F, Zamorano JD, Ramírez-Moreno JM, Jiménez-Caballero PE, Portilla-Cuenca JC, Lavado-García JM, et al. Determinants of quality of life in stroke survivors after 6 months, from a comprehensive stroke unit: a longitudinal study. Biological Research for Nursing 2014;epub ahead of print:pii: 1099800414553658.
78. Maitland K, Kiguli S, Opoka RO, Engoru C, Olupot-Olupot P, Akech SO, et al. Mortality after fluid bolus in African children with severe infection. The New England Journal of Medicine 2011;364(26):2483-95.
79. Mast H, Marx P. Neurological deterioration under isovolemic hemodilution with hydroxyethyl starch in acute cerebral ischemia. Stroke 1991;22:955.
80. Myburgh JA, Mythen MG. Resuscitation fluids. The New England Journal of Medicine 2013;369(13):1243-51. [PUBMED: 24066745]
81. NICE: National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. http://www.nice.org.uk/guidance/index.jsp?action=byID&o=14330 2013.
82. Reith J, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997;28(8):1585-9. [PUBMED: 9259753]
83. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
84. Rowat A, Graham C, Dennis M. Dehydration in hospital-admitted stroke patients. Stroke 2012;43:857-9.
85. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine 2004;350:2247-56.
86. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke 1999;30(4):793-9. [PUBMED: 10187881]
87. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta 2010;1802(1):80-91. [PUBMED: 19751827]
88. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke I. Results in the total patient population. Stroke 1987;18:691-9.
89. Truelsen T, Begg S, Mathers C. The global burden of cerebrovascular disease. World Health Organization. http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf 2000.
90. World Health Organization. Cerebrovascular Disorders. Geneva: World Health Organization, 1978.